Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Jun;24(2):287-289.
doi: 10.1007/s42000-025-00697-5.

GLP-1 agonists on a roll: from obesity to psoriasis - an elixir to watch!

Constantine A Stratakis  1   2   3   4
Affiliations
Editorial

GLP-1 agonists on a roll: from obesity to psoriasis - an elixir to watch!

Constantine A Stratakis. Hormones (Athens). 2025 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interest: The authors reports no conflicts of interest related to the matters covered by this Editorial. Prof. Stratakis consults for Astra Zeneca, Sterotherapeutics, and ELPEN pharmaceutical companies, has received research funding from Pfizer, and has patents on the PRKAR1A, PDE11A and GPR101 genes.

Similar articles

See all similar articles

References

    1. Paschou IA, Sali E, Paschou SA, Psaltopoulou T, Nicolaidou E, Stratigos AJ (2025) GLP-1RAs in patients with psoriasis. Hormones (Athens). https://doi.org/10.1007/s42000-025-00635-5 - DOI - PubMed
    1. Karacabeyli D, Lacaille D (2024) Glucagon-like peptide 1 receptor agonists in patients with inflammatory arthritis or psoriasis: a scoping review. J Clin Rheumatol 30(1):26–31. https://doi.org/10.1097/RHU.0000000000001949 - DOI - PubMed
    1. Pierret ACS, Mizuno Y, Saunders P et al (2025) Glucagon-like peptide 1 receptor agonists and mental health: a systematic review and meta-analysis. JAMA Psychiat 14:e250679. https://doi.org/10.1001/jamapsychiatry.2025.0679 - DOI
    1. Sghayyer M, Saleem D, Abua Daya H (2025) OR3–2 | GLP-1 receptor agonist use in patients with type II diabetes after acute myocardial infarction and PCI: a retrospective cohort study. https://doi.org/10.1016/j.jscai.2025.102704
    1. Martinelli S, Mazzotta A, Longaroni M, Petrucciani N (2024) Potential role of glucagon-like peptide-1 (GLP-1) receptor agonists in substance use disorder: a systematic review of randomized trials. Drug Alcohol Depend 264:112424. https://doi.org/10.1016/j.drugalcdep.2024.112424 - DOI - PubMed

Publication types

LinkOut - more resources